Genomic DNA purified from DRG and spinal cord tissues using Quick-gDNA MiniPrep Kit (Cat# 11–317AC; Genesee, San Diego, CA). PCR was performed using 5X HOT FIREPol Evagreen (Cat# 08–24-00020; Solis Biodyne, Tartu, Estonia) according to the manufacturer’s instructions. Specific primer sequences used are given in Supplementary Figure 1 (available online at http://links.lww.com/PAIN/A446). PCR efficiency was tested by running the samples on a 1% agarose gel containing SYBR Safe DNA Gel Stain (Cat# S33102; Thermo Fisher Scientific). Samples were sent for Sanger sequencing and obtained sequences were analyzed by alignment with the target regions within the Rattus norvegicus genome. As a control for off-target effects of our CRISPR/Cas9 editing strategy, we sequenced 11 potential off-target binding sites predicted using COSMID (crispr.bme.gatech. edu).10 (link) We sequenced 11 genomic regions, in 16 tissues, DRG (L4, L5, and L6) and dorsal horn of the lumbar region of the spinal cord (n = 4 controls and n = 4 CRISPR Nf1 per tissue). We found only 1 occurrence of an off-target alteration among the 176 sites screened (Supplementary Figure 1, available online at http://links.lww.com/PAIN/A446); this occurred in a noncoding region of the DNA.